FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; CODEINE PHOSPHATE | 71930-054-12 | Eywa Pharma Inc | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 50090-5200-2 | A-S Medication Solutions | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 72162-2001-5 | Bryant Ranch Prepack | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 71335-1846-8 | Bryant Ranch Prepack | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 71335-1846-5 | Bryant Ranch Prepack | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 58602-882-21 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 58602-882-38 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 79903-216-10 | WALMART INC. | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 21130-074-07 | Better Living Brands, LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-09 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-90 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-03 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-07 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-21 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-02 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-34 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-38 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-36 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 72288-376-20 | Amazon.com Services LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 21130-074-21 | Better Living Brands, LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-14 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 21130-074-14 | Better Living Brands, LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70010-669-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-670-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-667-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-667-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-668-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70010-669-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-670-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-668-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
-